Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 667

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The History of Photodetection and Photodynamic Therapy¶

Ackroyd, Roger, Kelty, Clive, Brown, Nicola, Reed, Malcolm·2007·Photochemistry and Photobiology
DOI 10.1562/0031-8655(2001)0740656thopap2.0.co2
Open this paper in CoChat — free account

Abstract

Light has been employed in the treatment of disease since antiquity. Many ancient civilizations utilized phototherapy, but it was not until early last century that this form of therapy reappeared. Following the scientific discoveries by early pioneers such as Finsen, Raab and Von Tappeiner, the combination of light and drug administration led to the emergence of photochemotherapy as a therapeutic tool. The isolation of porphyrins and the subsequent discovery of their tumor-localizing properties and phototoxic effects on tumor tissue led to the development of modern photodetection (PD) and photodynamic therapy (PDT). This review traces the origins and development of PD and PDT from antiquity to the present day.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1562/0031-8655(2001)0740656thopap2.0.co2

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 146

  1. Weishaupt, 1976, Identification of singlet oxygen as cytotoxic agent in photo-inactivation of a murine tumor, Cancer Res, 36, 2326
  2. Dougherty, 1975, Photoradiation therapy II: cure of animal tumors with haematoporphyrin and light, J. Natl. Cancer Inst, 55, 115, 10.1093/jnci/55.1.115 · DOI · Paper page
  3. Pass, 1993, Photodynamic therapy in oncology: mechanisms and clinical use, J. Natl. Cancer Inst, 85, 443, 10.1093/jnci/85.6.443 · DOI · Paper page
  4. Daniell, 1991, A history of photodynamic therapy, Aust. N.Z. J. Surg, 61, 340, 10.1111/j.1445-2197.1991.tb00230.x · DOI · Paper page
  5. Spikes, 1985, Primary Photoprocesses in Biology and Medicine, 209, 10.1007/978-1-4684-1224-6_12 · DOI
  6. Epstein, 1990, Phototherapy and photochemotherapy, N. Engl. J. Med, 32, 1149, 10.1056/NEJM199004193221609 · DOI · Paper page
  7. Cauvin , J. F. 1815 Des bienfaits de l'insolation Ph.D. Thesis University of Paris
  8. Finsen, 1901, Phototherapy
  9. Fitzpatrick, 1959, Historical aspects of methoxsalen and other furocoumarins, J. Investig. Dermatol, 23, 229, 10.1038/jid.1959.40 · DOI
  10. Raab, 1900, Uber die Wirkung fluoreszierender Stoffe auf Infusorien, Z. Biol, 39, 524
  11. Prime, 1900, Les accidentes toxiques par l'eosinate de sodium
  12. Von Tappeiner, 1903, Therapeutische Versuche mit fluoreszierenden Stoffen, Muench. Med. Wochenschr, 47, 2042
  13. Von Tappeiner, 1904, Uber Wirkung der photodynamischen (fluorieszierenden) Stoffe auf Protozoan und Enzyme, Dtsch. Arch. Klin. Med, 80, 427
  14. Von Tappeiner, 1907, Gesammte Untersuchungen uber die photodynamische Erscheinung
  15. Scherer , H. 1841 Chemisch-physiologische untersuchungen Ann. Chem. Pharm 40 1 · doi:10.1002/jlac.18410400102
  16. Thudichum, 1867, Tenth Report of the Medical Officer of the Privy Council
  17. Hoppe-Seyler, 1871, Med. Chem. Untersuchungen
  18. Hausmann, 1911, Die sensibilisierende Wirkung des Hematoporphyrins, Biochem. Z, 30, 276
  19. Meyer-Betz, 1913, Untersuchungen uber die Biologische (photodynamische) Wirkung des Hamatoporphyrins und anderer Derivative des Blut- und Galenfarbstoffs, Dtsch. Arch. Klin. Med, 112, 476
  20. Policard, 1924, Etudes sur les aspects offerts par des tumeurs experimentales examinees a la lumiere de Wood, C. R. Soc. Biol, 91, 1423
  21. Auler, 1942, Untersuchungen uber die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren, Z. Krebsforsch, 53, 65, 10.1007/BF01792783 · DOI · Paper page
  22. Figge, 1948, Cancer detection and therapy. Affinity of neoplastic, embryonic and traumatized regenerating tissues for porphyrins and metalloporphyrins, Proc. Soc. Exp. Biol. Med, 68, 640, 10.3181/00379727-68-16580 · DOI · Paper page
  23. Manganiello, 1951, Cancer detection and therapy II. Methods of preparation and biological effects of metalloporphyrins, Bull. School Med., Univ. Maryland, 36, 3
  24. Rassmussan-Taxdal, 1955, Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin, Cancer, 8, 78, 10.1002/1097-0142(1955)8:1<78::AID-CNCR2820080109>3.0.CO;2-L · DOI · Paper page
  25. Peck, 1955, Use of hematoporphyrin fluorescence in biliary and cancer surgery, Ann. Surg, 21, 181
  26. Schwartz, 1955, Some relationships of porphyrins, x-rays and tumours, Univ. Minn. Med. Bull, 27, 7
  27. Lipson, 1960, The photodynamic properties of a particular hematoporphyrin derivative, Arch. Dermatol, 82, 508, 10.1001/archderm.1960.01580040026005 · DOI · Paper page
  28. Lipson, 1961, The use of a derivative of hematoporphyrin in tumor detection, J. Natl. Cancer Inst, 26, 1
  29. Lipson, 1961, Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease, J. Thorac. Cardiovasc. Surg, 42, 623, 10.1016/S0022-5223(19)32560-7 · DOI · Paper page
  30. Lipson, 1967, Hematoporphyrin derivative for detection and management of cancer, Cancer, 20, 255, 10.1002/1097-0142(196712)20:12<2255::AID-CNCR2820201229>3.0.CO;2-U · DOI · Paper page
  31. Gray, 1967, Use of hematoporphyrin derivative in detection and management of cervical cancer, Am. J. Obstet. Gynecol, 99, 766, 10.1016/0002-9378(67)90392-4 · DOI
  32. Gregorie , H. B. Jr. E. O. Horger J. L. Ward J. F. Green T. Richards H. C. Robertson Jr. T. B. Stevenson 1968 Hematoporphyrin derivative fluorescence in malignant neoplasms Ann. Surg 167 829 · DOI · Paper page
  33. Leonard, 1971, Hematoporphyrin fluorescence: an aid to diagnosis of malignant neoplasms, Laryngoscope, 81, 365, 10.1288/00005537-197103000-00003 · doi:10.1288/00005537-197103000-00003
  34. Kyriazis, 1973, Hematoporphyrin derivative fluorescence test colposcopy and colpophotography in the diagnosis of atypical metaplasia, dysplasia and carcinoma in situ of the cervix uteri, Am. J. Obstet. Gynecol, 117, 375, 10.1016/0002-9378(73)90041-0 · doi:10.1016/0002-9378(73)90041-0
  35. Kinsey, 1978, Detection of hematoporphyrin fluorescence during fibreoptic bronchoscopy to localize early bronchogenic carcinoma, Mayo Clin. Proc, 53, 594
  36. Cortese, 1979, Clinical application of a new endoscopic technique for detection of in situ bronchial carcinoma, Mayo Clin. Proc, 54, 635
  37. Profio, 1979, Laser fluorescence bronchoscope for localization of occult lung tumours, Med. Phys, 6, 523, 10.1118/1.594617 · doi:10.1118/1.594617
  38. Hayata, 1983, Laser and Hematoporphyrin Derivative in Cancer
  39. Hayata, 1982, Fiberoptic bronchoscopic laser photoradiation for tumor localization in lung cancer, Chest, 82, 10, 10.1378/chest.82.1.10 · doi:10.1378/chest.82.1.10
  40. Benson, 1983, Treatment of transitional cell carcinoma of the bladder with hematopophyrin derivative phototherapy, J. Urol, 130, 1090, 10.1016/S0022-5347(17)51699-7 · DOI
  41. Profio, 1987, Dose measurement in photodynamic therapy of cancer, Lasers Surg. Med, 7, 71
  42. Diamond, 1972, Photodynamic therapy of malignant tumours, Lancet, 2, 1175, 10.1016/S0140-6736(72)92596-2 · DOI · Paper page
  43. Kelly, 1975, Photodynamic destruction of human bladder carcinoma, Br. J. Cancer, 31, 237, 10.1038/bjc.1975.30 · DOI · Paper page
  44. Kelly, 1976, Hematoporphyrin derivative: a possible aid in the diagnosis and treatment of carcinoma of the bladder, J. Urol, 115, 150, 10.1016/S0022-5347(17)59108-9 · DOI · Paper page
  45. Dougherty, 1978, Photoradiation therapy for the treatment of malignant tumours, Cancer Res, 36, 2628
  46. Wile, 1982, Laser photoradiation therapy of cancer following hematoporphyrin sensitization, Lasers Surg. Med, 2, 163, 10.1002/lsm.1900020206 · doi:10.1002/lsm.1900020206
  47. Wile, 1984, Laser photoradiation therapy of cancer: an update of the experience at the University of California, Irvine, Lasers Surg. Med, 4, 5, 10.1002/lsm.1900040103 · doi:10.1002/lsm.1900040103
  48. Tomio, 1984, Porphyrin Localization and Treatment of Tumors, 829
  49. Dougherty, 1987, Photosensitizers: therapy and detection of malignant tumors, Photochem. Photobiol, 45, 879, 10.1111/j.1751-1097.1987.tb07898.x · DOI · Paper page
  50. Balchum, 1984, Photoradiation therapy for endobronchial lung cancers employing the photodynamic action of hematoporphyrin derivative, Lasers Surg. Med, 4, 13, 10.1002/lsm.1900040104 · doi:10.1002/lsm.1900040104
  51. Lam, 1986, Predicting the response of obstructive endobronchial tumors to photodynamic therapy, Cancer, 58, 2298, 10.1002/1097-0142(19861115)58:10<2298::AID-CNCR2820581024>3.0.CO;2-B · doi:10.1002/1097-0142(19861115)58:10<2298::aid-cncr2820581024>3.0.co;2-b
  52. Lo Cicero, 1990, Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer, Chest, 98, 97, 10.1378/chest.98.1.97 · DOI
  53. Hayata, 1982, Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer, Chest, 81, 269, 10.1378/chest.81.3.269 · DOI · Paper page
  54. Cortese , D. A. J. H. Kinsey 1984 Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma Chest 86 8 · DOI
  55. Ohi, 1983, Lasers and Hematoporphyrin Derivative in Cancer, 79
  56. Prout, 1987, Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional cell carcinoma of the bladder, N. Engl. J. Med, 317, 1251, 10.1056/NEJM198711123172003 · DOI · Paper page
  57. McCaughan, 1984, Palliation of oesophageal malignancy with photoradiation therapy, Cancer, 54, 2905, 10.1002/1097-0142(19841215)54:12<2905::AID-CNCR2820541215>3.0.CO;2-N · doi:10.1002/1097-0142(19841215)54:12<2905::aid-cncr2820541215>3.0.co;2-n
  58. Hayata, 1985, Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastro-intestinal tract, Semin. Surg. Oncol, 1, 1, 10.1002/ssu.2980010103 · doi:10.1002/ssu.2980010103
  59. Sibille, 1995, Long-term survival after photodynamic therapy for esophageal cancer, Gastroenterology, 108, 337, 10.1016/0016-5085(95)90058-6 · DOI · Paper page
  60. Ward, 1982, The treatment of vaginal recurrences of gynecological malignancy with phototherapy following hematoporphyrin derivative pre-treatment, Am. J. Obstet. Gynecol, 142, 356, 10.1016/0002-9378(82)90744-X · doi:10.1016/0002-9378(82)90744-x
  61. Gomer, 1983, Hematoporphyrin derivative photoradiation therapy for the treatment of intraocular tumors: examination of acute normal ocular toxicity, Cancer Res, 43, 721
  62. Tse, 1984, Hematoporphyrin photoradiation therapy for intra-ocular and orbital malignant melanoma, Arch. Ophthamol, 102, 833, 10.1001/archopht.1984.01040030653011 · doi:10.1001/archopht.1984.01040030653011
  63. Sandeman, 1986, Photodynamic therapy in the management of malignant gliomas: a review, Lasers Med. Sci, 1, 163, 10.1007/BF02040233 · doi:10.1007/bf02040233
  64. Hill, 1990, Selective uptake of hematoporphyrin derivative into human cerebral glioma, Neurosurgery, 26, 248, 10.1227/00006123-199002000-00011 · doi:10.1227/00006123-199002000-00011
  65. Schweitzer, 1990, Photodynamic therapy for treatment of head and neck cancer, Otolaryngol. Head Neck Surg, 102, 225, 10.1177/019459989010200304 · DOI
  66. Wenig, 1990, Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck, Arch. Otolaryngol. Head Neck Surg, 116, 1267, 10.1001/archotol.1990.01870110039003 · doi:10.1001/archotol.1990.01870110039003
  67. Barr, 1990, Photodynamic therapy for colorectal cancer: a quantitative pilot study, Br. J. Surg, 77, 93, 10.1002/bjs.1800770132 · DOI
  68. Dougherty, 1998, Photodynamic therapy, J. Natl. Cancer Inst, 90, 889, 10.1093/jnci/90.12.889 · DOI · Paper page
  69. Henderson, 1992, How does photodynamic therapy work?, Photochem. Photobiol, 55, 145, 10.1111/j.1751-1097.1992.tb04222.x · DOI · Paper page
  70. Henderson, 1984, Porphyrin Localization and Treatment of Tumors, 301
  71. Star, 1986, Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers, Cancer Res, 46, 2532
  72. Reed, 1989, A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation, Radiat. Res, 119, 542, 10.2307/3577525 · DOI
  73. Peng, 1996, Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy, Ultrastruct. Pathol, 20, 109, 10.3109/01913129609016306 · DOI · Paper page
  74. Moan, 1991, The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen, Photochem. Photobiol, 53, 549, 10.1111/j.1751-1097.1991.tb03669.x · DOI · Paper page
  75. Agarwal, 1991, Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells, Cancer Res, 51, 5993
  76. Kessel, 1998, Mitochondrial photodamage and PDT-induced apoptosis, J. Photochem. Photobiol. B: Biol, 42, 89, 10.1016/S1011-1344(97)00127-9 · DOI · Paper page
  77. Moor, 2000, Signaling pathways in cell death and survival after photodynamic therapy, J. Photochem. Photobiol. B: Biol, 57, 1, 10.1016/S1011-1344(00)00065-8 · DOI · Paper page
  78. Fingar, 1996, Vascular effects of photodynamic therapy, J. Clin. Laser Med. Surg, 14, 323, 10.1089/clm.1996.14.323 · DOI · Paper page
  79. Korbelik, 1996, Induction of tumor immunity by photodynamic therapy, J. Clin. Laser Med. Surg, 14, 329, 10.1089/clm.1996.14.329 · DOI · Paper page
  80. Korbelik, 1999, Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy, Cancer Lett, 137, 91, 10.1016/S0304-3835(98)00349-8 · DOI
  81. MacDonald, 2001, Basic principles of photodynamic therapy, J. Porphyrin Phthalocyanines, 5, 105, 10.1002/jpp.328 · DOI · Paper page
  82. Dougherty, 1983, Hematoporphyrin as a photosensitizer of tumors, Photochem. Photobiol, 38, 377, 10.1111/j.1751-1097.1983.tb02687.x · doi:10.1111/j.1751-1097.1983.tb02687.x
  83. Dougherty, 1984, Porphyrin Localization and Treatment of Tumors, 301
  84. Kessel, 1987, Chemistry of hematoporphyrin derived photosensitisers, Photochem. Photobiol, 46, 563, 10.1111/j.1751-1097.1987.tb04814.x · doi:10.1111/j.1751-1097.1987.tb04814.x
  85. Bown, 1986, Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver, Br. J. Cancer, 54, 43, 10.1038/bjc.1986.150 · DOI · Paper page
  86. Chan, 1986, Cell uptake, distribution and response to aluminium chloro-sulphonated phthalocyamine, a potential anti-tumour photosensitizer, Br. J. Cancer, 53, 255, 10.1038/bjc.1986.43 · doi:10.1038/bjc.1986.43
  87. Pope, 1991, The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization, J. Urol, 145, 1064, 10.1016/S0022-5347(17)38536-1 · DOI
  88. Berenbaum, 1986, Meso-tetra (hydroxyphenyl) porphyrins, a new class of potent tumour photosensitizers with favourable selectivity, Br. J. Cancer, 54, 717, 10.1038/bjc.1986.232 · DOI · Paper page
  89. Chevretton, 1992, The effect of photodynamic therapy on normal skeletal muscle in an animal model, Lasers Med. Sci, 7, 103, 10.1007/BF02594059 · doi:10.1007/bf02594059
  90. Berenbaum, 1993, Selectivity of meso-tetra-(hydroxyphenyl) porphyrins and chlorines and photofrin in causing photodamage in tumor, skin, muscle and bladder, Lasers Med. Sci, 8, 235, 10.1007/BF02547845 · DOI
  91. Drabkin , D. L. 1963 Introduction: some historical highlights in knowledge of porphyrins and porphyrias Ann. N. Y. Acad. Sci 104 658 · doi:10.1111/j.1749-6632.1963.tb17699.x
  92. Granick , S. 1965 Hepatic porphyria and drug-induced or chemical porphyria Ann. N. Y. Acad. Sci 123 188 · DOI
  93. Divaris, 1990, Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolaevulinic acid correlates with localized protoporphyrin production, Am. J. Pathol, 136, 891
  94. Elder, 1994, Scientific Foundations of Biochemistry in practise, 175
  95. Kennedy, 1992, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol, 14, 275, 10.1016/1011-1344(92)85108-7 · DOI
  96. Pottier, 1986, Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo, Photochem. Photobiol, 44, 679, 10.1111/j.1751-1097.1986.tb04726.x · DOI · Paper page
  97. Loh, 1993, Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract, J. Photochem. Photobiol. B: Biol, 20, 47, 10.1016/1011-1344(93)80130-2 · DOI
  98. Wyld, 1997, Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX, Br. J. Cancer, 76, 705, 10.1038/bjc.1997.450 · DOI
  99. Ackroyd, 2000, Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective double-blind randomised placebo-controlled trial, Gut, 47, 612, 10.1136/gut.47.5.612 · DOI · Paper page
  100. Young, 1996, Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer, Photochem. Photobiol, 63, 892, 10.1111/j.1751-1097.1996.tb09647.x · DOI · Paper page
  101. Rockson, 2000, An emerging clinical cardiovascular role for photodynamic therapy, Circulation, 102, 2322, 10.1161/01.CIR.102.19.2322 · DOI
  102. Sessler, 2000, Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy, Biochem. Pharmacol, 59, 733, 10.1016/S0006-2952(99)00314-7 · DOI · Paper page
  103. Mang, 1998, A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer, Cancer J. Sci. Am, 4, 378
  104. Kaplan, 1998, Photodynamic therapy in the management of metastatic cutaneous adenocarcinoma: case reports from phase ½ studies using tin ethyl etiopurpurin (SnET2), J. Surg. Oncol, 67, 121, 10.1002/(SICI)1096-9098(199802)67:2<121::AID-JSO9>3.0.CO;2-C · DOI
  105. Razum, 1996, SnET2: clinical update, Proc. SPIE, 2675, 43, 10.1117/12.237549 · DOI
  106. Pangka, 1986, Diels-Alder reactions of protoporphyrin XI dimethyl ester with electron deficient alkynes, J. Org. Chem, 51, 1094, 10.1021/jo00357a029 · doi:10.1021/jo00357a029
  107. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study group 1999 Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: one-year results of 2 randomised clinical trials-TAP report Arch. Ophthalmol 117 1329 1345 · DOI · Paper page
  108. Taber, 1998, Photodynamic therapy using mono-l-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study, Clin. Cancer Res, 4, 2741
  109. Kessel, 1997, Pharmacokinetics of N-aspartyl chlorin e6 in cancer patients, Photochem. Photobiol, 39, 81, 10.1016/S1011-1344(96)00009-7 · DOI
  110. Lightdale, 1995, Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial, Gastrointest. Endosc, 42, 507, 10.1016/S0016-5107(95)70002-1 · DOI · Paper page
  111. Overholt, 1999, Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients, Gastrointest. Endosc, 49, 1, 10.1016/S0016-5107(99)70437-2 · DOI · Paper page
  112. Barr, 1996, Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX, Lancet, 348, 584, 10.1016/S0140-6736(96)03054-1 · DOI · Paper page
  113. Gossner, 1998, Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid, Gastroenterology, 114, 448, 10.1016/S0016-5085(98)70527-X · DOI · Paper page
  114. Kennedy, 1992, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol, 14, 275, 10.1016/1011-1344(92)85108-7 · DOI
  115. Fink-Puches, 1997, Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light, J. Photochem. Photobiol. B: Biol, 41, 145, 10.1016/S1011-1344(97)00096-1 · DOI
  116. Cairnduff, 1994, Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer, Br. J. Cancer, 69, 605, 10.1038/bjc.1994.112 · DOI · Paper page
  117. Stables, 1997, Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy, Br. J. Dermatol, 136, 957, 10.1111/j.1365-2133.1997.tb03944.x · doi:10.1111/j.1365-2133.1997.tb03944.x
  118. Morton, 2001, Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma, Arch. Dermatol, 137, 319
  119. Soler, 1999, Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study, Acta Dermato-Venereol, 79, 204, 10.1080/000155599750010977 · DOI
  120. Kloek, 1998, Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin, Photochem. Photobiol, 67, 150, 10.1111/j.1751-1097.1998.tb05178.x · DOI · Paper page
  121. Moan, 2001, On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters, Int. J. Cancer, 92, 139, 10.1002/1097-0215(200102)9999:9999<::AID-IJC1154>3.0.CO;2-K · DOI
  122. Stender, 1999, Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study, Clin. Exp. Dermatol, 24, 154, 10.1046/j.1365-2230.1999.00441.x · DOI
  123. Stender, 2000, Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial, Lancet, 355, 963, 10.1016/S0140-6736(00)90013-8 · DOI · Paper page
  124. Robinson, 1999, Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy, Acta Dermato-Venereol, 79, 451, 10.1080/000155599750009898 · DOI
  125. Hongcharu, 2000, Topical ALA-photodynamic therapy for the treatment of acne vulgaris, J. Investig. Dermatol, 115, 183, 10.1046/j.1523-1747.2000.00046.x · DOI · Paper page
  126. Walther, 1997, Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder, Urology, 50, 199, 10.1016/S0090-4295(97)00211-2 · doi:10.1016/s0090-4295(97)00211-2
  127. Nseyo, 1998, Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder, J. Urol, 160, 39, 10.1016/S0022-5347(01)63021-0 · DOI
  128. Kriegmair, 1996, Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer, Br. J. Urol, 77, 667, 10.1046/j.1464-410X.1996.09717.x · DOI
  129. Waidelich, 2001, Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer, J. Urol, 165, 1904, 10.1016/S0022-5347(05)66239-8 · DOI
  130. Diaz-Jimenez, 1999, Efficacy and safety of photodynamic therapy versus Nd-YAG laser resection in NSCLC with airway obstruction, Eur. Respir. J, 14, 800, 10.1034/j.1399-3003.1999.14d13.x · DOI
  131. Sutedja, 1996, Photodynamic therapy in lung cancer. A review, J. Photochem. Photobiol. B: Biol, 36, 199, 10.1016/S1011-1344(96)07372-1 · DOI
  132. Furuse, 1993, A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group, J. Clin. Oncol, 11, 1844, 10.1200/JCO.1993.11.10.1852 · DOI · Paper page
  133. Biel, 1998, Photodynamic therapy and the treatment of head and neck neoplasia, Laryngoscope, 108, 1259, 10.1097/00005537-199809000-00001 · DOI
  134. Feyh, 1996, Photodynamic therapy for cancers of the head and neck, J. Photochem. Photobiol. B: Biol, 36, 175, 10.1016/S1011-1344(96)07366-6 · doi:10.1016/s1011-1344(96)07366-6
  135. Muller, 1995, Photodynamic therapy for recurrent supratentorial gliomas, Semin. Surg. Oncol, 11, 346, 10.1002/ssu.2980110504 · DOI
  136. Muller, 1996, Photodynamic therapy for malignant newly diagnosed supratentorial gliomas, J. Clin. Laser Med. Surg, 14, 263, 10.1089/clm.1996.14.263 · DOI
  137. Bauer, 2001, Preliminary report of photodynamic therapy for intraperitonelal sarcomatosis, Ann. Surg. Oncol, 8, 254, 10.1007/s10434-001-0254-7 · doi:10.1007/s10434-001-0254-7
  138. Moskal, 1998, Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up, Ann. Thorac. Surg, 66, 1128, 10.1016/S0003-4975(98)00799-1 · DOI
  139. Datta, 1998, Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma, Br. J. Cancer, 78, 1113, 10.1038/bjc.1998.637 · DOI
  140. Kriegmair, 1999, Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy, Eur. Urol, 36, 386, 10.1159/000020019 · DOI
  141. Jichlinski , P. G. Wagnieres M. Forrer J. Mizeret L. Guillou M. Oswald F. Schmidlin P. Graber H. Van den Bergh H. J. Leisinger 1997 Clinical assessment of fluorescence cytoscopy during transurethral bladder resection in superficial bladder cancer Urol. Res 25 S3 6 · DOI
  142. Filbeck, 2000, No generalized skin phototoxicity after intravesical application of 5-aminolevulinic acid for fluorescence diagnosis of superficial bladder cancer, Urol. Int, 64, 126, 10.1159/000030511 · DOI
  143. Baumgartner, 1996, Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer, J. Photochem. Photobiol. B: Biol, 36, 169, 10.1016/S1011-1344(96)07365-4 · DOI
  144. Messmann, 2000, 5-aminolevulinic acid-induced protoporhyrin IX for the detection of gastrointestinal dysplasia, GI Endosc. Clin. N. Am, 10, 497, 10.1016/S1052-5157(18)30119-3 · DOI
  145. Ladner, 2001, Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid, Br. J. Cancer, 84, 33, 10.1054/bjoc.2000.1532 · DOI
  146. Whitehurst, 1993, Development of an alternative light source to lasers for photodynamic therapy: 1. Comparative in vitro dose response characteristics, Lasers Med. Sci, 8, 259, 10.1007/BF02547849 · DOI

Cited by

See all 667

Metadata

Authors
Ackroyd, R., Kelty, C., Brown, N., & Reed, M.
Venue
Photochemistry and Photobiology
Publisher
American Society for Photobiology
Published
2007-05-01
Volume
74
Issue
5
Pages
656-669
ISSN
0031-8655 (ISSN-L)
DOI
10.1562/0031-8655(2001)0740656thopap2.0.co2
OpenAlex
W1897342331
Cited by
667
References
5
FWCI
16.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The History of Photodetection and Photodynamic Therapy¶. https://app.cochat.ai/papers/10.1562/0031-8655(2001)0740656thopap2.0.co2
The paper
Ackroyd, R., Kelty, C., Brown, N., & Reed, M. (2007). The History of Photodetection and Photodynamic Therapy¶. Photochemistry and Photobiology. https://doi.org/10.1562/0031-8655(2001)0740656thopap2.0.co2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.